Equities analysts predict that Livent Co. (NYSE:LTHM – Get Rating) will announce earnings of $0.28 per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Livent’s earnings, with the highest EPS estimate coming in at $0.34 and the lowest estimate coming in at $0.15. Livent posted earnings per share of $0.04 in the same quarter last year, which indicates a positive year over year growth rate of 600%. The company is scheduled to announce its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that Livent will report full-year earnings of $1.10 per share for the current fiscal year, with EPS estimates ranging from $0.61 to $1.35. For the next fiscal year, analysts forecast that the company will post earnings of $1.38 per share, with EPS estimates ranging from $0.63 to $1.69. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Livent.
Livent (NYSE:LTHM – Get Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.07. Livent had a net margin of 11.56% and a return on equity of 8.69%. The company had revenue of $143.50 million during the quarter, compared to analyst estimates of $139.92 million. During the same period in the prior year, the business posted $0.02 EPS. The firm’s revenue was up 56.5% compared to the same quarter last year.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LTHM. Bessemer Group Inc. grew its holdings in Livent by 77.7% during the 4th quarter. Bessemer Group Inc. now owns 1,189 shares of the company’s stock valued at $29,000 after buying an additional 520 shares in the last quarter. GoalVest Advisory LLC purchased a new stake in Livent during the 1st quarter valued at approximately $39,000. Quadrant Capital Group LLC grew its holdings in Livent by 40.7% during the 1st quarter. Quadrant Capital Group LLC now owns 1,583 shares of the company’s stock valued at $41,000 after buying an additional 458 shares in the last quarter. IFP Advisors Inc grew its holdings in Livent by 75.0% during the 4th quarter. IFP Advisors Inc now owns 1,750 shares of the company’s stock valued at $42,000 after buying an additional 750 shares in the last quarter. Finally, Point72 Hong Kong Ltd purchased a new stake in Livent during the 4th quarter valued at approximately $50,000. Institutional investors own 97.33% of the company’s stock.
Livent stock traded down $0.42 during mid-day trading on Tuesday, reaching $23.91. 187,598 shares of the company traded hands, compared to its average volume of 2,810,925. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.03 and a quick ratio of 2.02. The firm’s 50 day moving average price is $24.10 and its 200 day moving average price is $25.18. The firm has a market capitalization of $3.87 billion, a price-to-earnings ratio of 88.26, a P/E/G ratio of 1.12 and a beta of 2.03. Livent has a 52-week low of $16.32 and a 52-week high of $33.04.
Livent Company Profile (Get Rating)
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.
Recommended Stories
- Get a free copy of the StockNews.com research report on Livent (LTHM)
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
Get a free copy of the Zacks research report on Livent (LTHM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.